Effect of the COVID-19 Pandemic on Paediatric Check-Ups and Vaccinations in Germany

Author:

Lindinger Rudolf1,Richter Hartmut2,Reuter Thorsten Christian1,Fischer Tim1

Affiliation:

1. Medical Affairs Department, MSD Sharp & Dohme GmbH, 81673 Munich, Germany

2. IQVIA Commercial GmbH & Co. OHG, 60549 Frankfurt, Germany

Abstract

Paediatric check-ups and vaccinations are provided and free of charge in Germany. Despite being hitherto generally well-received and adhered to, it is possible that the lockdown implemented due to the COVID-19 pandemic resulted in delays or even cancellations of critical paediatric visits with healthcare providers. This study attempts to quantify the rate and time to follow-up for check-ups in Germany using the retrospective IQVIATM Disease Analyzer database. Additionally, timely administration of 4 vaccines (Hexavalent, pneumococcal, MMR-V, Rotavirus) was analysed to examine the impact of pandemic restrictions on vaccine uptake. The timeframes which were compared to determine the effects of COVID-19 were June 2018–December 2019 and March 2020–September 2021. The follow-up rates for paediatric check-ups were consistently lower in the COVID-19 phase, but generally ~90%. Follow-up rates for the vaccinations were distinctly higher during COVID-19. The time between events was almost unchanged for check-ups during the pandemic. For check-ups, age at initial event differed by less than a week between the phases. For vaccinations, the age differences were slightly higher, but exceeded one week in only two cases. The results show that the COVID-19 pandemic had little effect on paediatric check-ups and vaccinations in Germany.

Funder

MSD Sharp & Dohme GmbH

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

Reference19 articles.

1. Triumphs of immunization;Modlin;J. Infect. Dis.,2021

2. Mumps Orchitis: Clinical aspects and mechanisms;Wu;Front. Immunol.,2021

3. Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch Institut 2020/2021;Kling;Epid. Bull.,2020

4. (2023, February 07). Benefits of the Statutory Health Insurance in Germany: § 26 SGB V. Available online: https://www.sozialgesetzbuch-sgb.de.

5. Characteristics of and important lessons from the Coronavirus disease 2019 (COVID-19) outbreak in China;Wu;JAMA,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3